Adherent leukoma
ICD-10 H17.0 is a used to indicate a diagnosis of adherent leukoma.
Adherent leukoma, also known as corneal leukoma, is characterized by a dense, opaque area on the cornea that can result from various etiologies, including trauma, infection, or inflammation. Clinically, it presents as a white or grayish area on the cornea, which may be associated with visual impairment depending on its size and location. The anatomy involved primarily includes the cornea, which is the transparent front part of the eye, and may also involve adjacent structures such as the conjunctiva and sclera if the leukoma is extensive. Disease progression can lead to complications such as corneal scarring, neovascularization, and potential loss of vision. Diagnostic considerations include a thorough ocular examination, slit-lamp biomicroscopy, and possibly imaging studies to assess the extent of corneal involvement. Differential diagnoses may include other forms of corneal opacities, such as corneal dystrophies or scars from previous infections. Accurate diagnosis is crucial for determining the appropriate management and treatment options, which may include surgical intervention or therapeutic contact lenses.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H17.0 covers adherent leukoma resulting from various causes such as trauma, infections like herpes simplex keratitis, or inflammatory conditions. It is characterized by a significant opacity on the cornea that adheres to underlying tissues.
H17.0 should be used when the leukoma is adherent and associated with significant corneal scarring or opacification. It is differentiated from H17.1 when the leukoma does not adhere to the underlying corneal stroma.
Documentation should include a detailed ocular examination report, findings from slit-lamp examination, and any imaging studies that confirm the presence and extent of the adherent leukoma.
